{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:57Z","timestamp":1791322317168,"version":"4.3.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81172867"],"award-info":[{"award-number":["81172867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cyto.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:33:08Z","timestamp":1375230788000},"page":"22-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren\u2019s Syndrome"],"prefix":"10.1016","volume":"64","author":[{"given":"Lin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2013.07.006_b0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cyto.2013.07.006_b0010","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","article-title":"IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex","volume":"179","author":"Chackerian","year":"2007","journal-title":"J Immunol"},{"issue":"36","key":"10.1016\/j.cyto.2013.07.006_b0015","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.cyto.2013.07.006_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals","volume":"82","author":"Ho","year":"2007","journal-title":"J Leukocyte Biol"},{"issue":"9","key":"10.1016\/j.cyto.2013.07.006_b0025","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","article-title":"Measurement of interleukin-33(IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis","volume":"26","author":"Hong","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.cyto.2013.07.006_b0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2222.2011.03867.x","article-title":"The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis","volume":"42","author":"Kamekura","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.cyto.2013.07.006_b0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.cyto.2013.07.006_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s Syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2013.07.006_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","article-title":"Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis","volume":"58","author":"Xiangyang","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2013.07.006_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3899\/jrheum.090492","article-title":"Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis","volume":"37","author":"Matsuyama","year":"2010","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.cyto.2013.07.006_b0055","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3899\/jrheum.100184","article-title":"Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis","volume":"37","author":"Mu","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.cyto.2013.07.006_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10238-010-0115-4","article-title":"Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population","volume":"11","author":"Yang","year":"2011","journal-title":"Clin Exp Med"},{"issue":"9","key":"10.1016\/j.cyto.2013.07.006_b0065","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.1201042109","article-title":"Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice","volume":"109","author":"Yasuda","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2013.07.006_b0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-009-0244-9","article-title":"ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells","volume":"335","author":"Aoki","year":"2010","journal-title":"Mol Cell Biochem"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613006005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613006005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T03:28:43Z","timestamp":1539487723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466613006005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1043466613006005"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2013.07.006","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren\u2019s Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2013.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}